ukplan.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
Form 11-K
 
 
[ X
]
ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 [NO FEE REQUIRED] FOR THE FISCAL YEAR ENDED JUNE 30, 2010, OR
 
[
]
TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 [NO FEE REQUIRED] for the transition period from _________ to__________.
 
 
Commission file number 001-00434
 
A.
Full title of the plan and the address of the plan, if different from that of the issuer named below:  Procter & Gamble 1-4-1 Plan, Procter & Gamble Technical Centres Limited, Cobalt 12, Silver Fox Way, Cobalt Business Park, Newcastle upon Tyne NE27 0QW.
 
B.
Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:  The Procter & Gamble Company, One Procter & Gamble Plaza, Cincinnati, Ohio 45202
 
 
REQUIRED INFORMATION
 
Item 1.
Audited statements of financial condition as of the end of the latest two fiscal years of the plan (or such lesser period as the plan has been in existence). (See Page 2)
 
Item 2.
Audited statements of income and changes in plan equity for each of the latest three fiscal years of the plan (or such lesser period as the plan has been in existence). (See Page 3)



 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
   
PROCTER & GAMBLE
1-4-1 PLAN
 
Statements of Net Assets Available for Plan Benefits as of June 30, 2010 and 2009, Statements of Changes in Net Assets Available for Plan Benefits for the Years Ended June 30, 2010, 2009 and 2008, and Report of Independent Registered Public Accounting Firm
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
 

 
 TABLE OF CONTENTS
     
     Page
     
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM     1
     
FINANCIAL STATEMENTS:    
     
    Statements of Net Assets Available for Plan Benefits as of June 30, 2010 and 2009    2
     
    Statements of Changes in Net Assets Available for Plan Benefits for the Years Ended
    June 30, 2010, 2009 and 2008
    3
     
     Notes to Financial Statements for the Years Ended June 30, 2010, 2009 and 2009    4
     
     
     
 



 
 
 
 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
To the Trustees of the Procter & Gamble 1-4-1 Plan:
 
We have audited the accompanying statements of net assets available for plan benefits of the Procter & Gamble 1-4-1 Plan (“the Plan”) as of June 30, 2010 and 2009, and the related statements of changes in net assets available for plan benefits for the years ended June 30, 2010, 2009 and 2008.  These financial statements are the responsibility of the Plan’s management.  Our responsibility is to express an opinion on these financial statements based on our audits.
 
We conducted our audits in accordance with standards of the Public Company Accounting Oversight Board (United States).  Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.  We believe that our audits provide a reasonable basis for our opinion.
 
In our opinion, such financial statements present fairly, in all material respects, the net assets available for plan benefits of the Plan as of June 30, 2010 and 2009 and the changes in net assets available for plan benefits for the years ended June 30, 2010, 2009 and 2008, in conformity with accounting principles generally accepted in the United States of America.
 
 
 
/s/ Deloitte LLP
 
 
Newcastle upon Tyne, United Kingdom
 
28 September 2010
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-1-
 
 
 
PROCTER & GAMBLE
1-4-1 PLAN
 
 
 
 
STATEMENTS OF NET ASSETS AVAILABLE FOR PLAN BENEFITS
JUNE 30, 2010 AND 2009
 


 
2010
2009
 
£
£
ASSETS:
    
  Investment in The Procter & Gamble Company common stock, at fair value
45,111,617
33,268,992
  Cash at bank and in hand
845,659
720,577
           Total assets
45,957,276
33,989,569
     
LIABILITIES:
    
  Amounts due to others
                 (104,549)
                   (71,098)
  Contributions received in advance
                 (728,532)
                 (636,321)
          Total liabilities
                 (833,081)
                 (707,419)
     
NET ASSETS AVAILABLE FOR PLAN BENEFITS
45,124,195
33,282,150
     
See notes to financial statements.
    

 
-2-
 
 

PROCTER & GAMBLE
1-4-1 PLAN
 
 
 
 
STATEMENTS OF CHANGES IN NET ASSETS AVAILABLE FOR PLAN BENEFITS
YEARS ENDED JUNE 30, 2010, 2009 AND 2008
 

 
2010
2009
2008
 
£
£
£
ADDITIONS (LOSSES):
      
  Investment income:
      
    Net appreciation/(depreciation) in fair value of
      
    The Procter & Gamble Company common stock
9,577,551
(347,715)
(23,872)
    Dividends from The Procter & Gamble Company
    common stock
1,045,462
849,992
522,807
     Total investment gain
10,623,013
502,277
498,935
  Contributions:
      
    Contributions from participating Procter & Gamble
    companies
3,503,180
3,483,476
3,577,341
    Contributions from participants
3,503,180
3,483,476
3,577,341
     Total contributions
7,006,360
6,966,952
7,154,682
  Income from participating Procter & Gamble
  companies
35,297
17,045
11,562
           Total additions
17,664,670
7,486,274
7,665,179
       
DEDUCTIONS:
      
  Distributions and withdrawals to participants
(5,787,328)
(4,549,011)
(2,742,183)
  Administrative expenses
(35,297)
(17,045)
(11,562)
           Total deductions
(5,822,625)
(4,566,056)
(2,753,745)
       
NET INCREASE
11,842,045
2,920,218
4,911,434
       
NET ASSETS AVAILABLE FOR PLAN BENEFITS:
      
  Beginning of year
33,282,150
30,361,932
25,450,498
       
  End of year
45,124,195
33,282,150
30,361,932
       
See notes to financial statements.
      

 
-3-
 
 

PROCTER & GAMBLE
1-4-1 PLAN
 
 
 
 
NOTES TO FINANCIAL STATEMENTS
YEARS ENDED JUNE 30, 2010, 2009 AND 2008
 


1.
PLAN DESCRIPTION
 
The following brief description of the Procter & Gamble 1-4-1 Plan (“Plan”) is provided for general information purposes only.  Participants should refer to the Plan agreement for more complete information.
 
General - The Plan is a share purchase plan established on October 1, 2002 by The Procter & Gamble Company (“Company”), replacing the Procter & Gamble Matched Savings Share Purchase Plan, which ceased to be tax efficient from this date, to provide a means for eligible United Kingdom (“UK”) employees to tax efficiently purchase shares in the Company. The Plan is administered by Capita IRG Trustees Limited who were appointed by the Trustees of the Plan and hold the Plan assets on behalf of the Trustees of the Plan.
 
Contributions- Contributions represent cash amounts received from members, matched by the sponsoring companies (note 8), that have been invested in stock of The Procter & Gamble Company. Where cash amounts are received from members and matched by the sponsoring companies, but have not yet been invested in stock of The Procter & Gamble Company, they are deferred on the balance sheet.
 
Participant Accounts – Individual accounts are maintained for each Plan participant. Each participant’s account is credited with the participant’s contribution, the participating Procter & Gamble company’s matching contribution, and allocations of Plan earnings, and charged with withdrawals and an allocation of Plan losses. Allocations are based on participant earnings or account balances, as defined.  The distribution to which a participant is entitled is limited to the shares that can be provided from the participant’s account.
 
Vesting – Participants are vested immediately in all shares allocated to their account.
 
Investments – Participants are only permitted to invest in Company common stock. Any dividends on shares of Company common stock are invested in additional shares of Company common stock.
 
Participant Loans – Under the terms of the Plan agreement, participants are not permitted to borrow funds from their account balance.
 
Distributions and Withdrawals – Participants may withdraw contributory shares from the Plan at any time; however, participants who withdraw contributory shares from the Plan within five years of acquisition will become liable for UK income tax and national insurance. Participants cannot withdraw matching shares from the Plan within 5 years of purchase, and cannot withdraw dividend shares from the Plan within 3 years of purchase, unless the participant ceases to be an employee of the participating Procter & Gamble companies.
 

 
-4-
 
 

 


2.
SIGNIFICANT ACCOUNTING POLICIES
 
Basis of Accounting - The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America.
 
Use of Estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires Plan management to make estimates and assumptions that affect the reported amounts of net assets available for plan benefits and changes therein.  Actual results could differ from those estimates.
 
Risks and Uncertainties - The Plan invests in Company common stock which represents a concentration in investments. Investment securities, in general, are exposed to various risks, such as interest rate, credit and overall market volatility.  Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in values of investment securities will occur in the near term and that such changes could materially affect the amounts reported in the financial statements.
 
Investment Valuation and Income Recognition- The Plan’s investment in Company common stock is stated at fair value, which is based on quoted market prices and is translated into sterling at the rate of exchange at June 30. Purchases and sales of securities are recorded on a trade date basis. Dividends are recorded on the ex-dividend date.
 
Fair Value Measurements  - FASB Accounting Standards Codification (ASC) Topic 820, establishes a framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described as follows:
 
Level 1
  
Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the plan has the ability to access.
     
Level 2
  
Inputs to the valuation methodology include
• quoted prices for similar assets or liabilities in active markets;
• quoted prices for identical or similar assets or liabilities in inactive markets;
• inputs other than quoted prices that are observable for the asset or liability;
• inputs that are derived principally from or corroborated by observable market data by correlation or other means.
If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.
     
Level 3   Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
 
The asset or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.
 
 
 
All investments are measured following a Level 1 valuation technique.
 
Net Appreciation / (Depreciation)  in Fair Value of Investments - Realised and unrealised appreciation / (depreciation) in fair value of investments is based on the difference between the fair value of the assets at the beginning of the year, or at the time of purchase for assets purchased during the year, and the related  fair value on the day investments are sold with respect to realised appreciation / (depreciation), or on the last day of the year for unrealised appreciation / (depreciation).

 
-5-
 
 

 
 
Cash at Bank and In Hand – Amounts shown as cash at bank and in hand are uninvested funds held that are to be invested in Company common stock in the following month.
 
Expenses of the Plan - Investment management expenses and all other fees and expenses are reimbursed by the participating Procter & Gamble companies (see Note 8).
 
Distributions and Withdrawals (Amounts due to others) – Distributions and withdrawals to participants are recorded upon distribution. Amounts allocated to accounts of persons who have elected to withdraw from the Plan but have not yet been paid were £76,525 and £60,977 at June 30, 2010 and 2009, respectively.
 
New Accounting Standards - In June 2009, the FASB issued ASC Topic 105-10, “Generally Accepted Accounting Principles — Overall” (“ASC 105-10”). ASC 105-10 establishes the FASB Accounting Standards Codification (the “Codification”) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with U.S. GAAP. Rules and interpretive releases of the SEC under authority of federal securities laws are also sources of authoritative GAAP for SEC registrants. All guidance contained in the Codification carries an equal level of authority. The Codification superseded all existing non-SEC accounting and reporting standards. The Codification does not change current U.S. GAAP, but is intended to simplify user access to all authoritative U.S. GAAP by providing all authoritative literature related to a particular topic in one place. The adoption changed certain disclosure references to U.S. GAAP, but did not have any other impact on the Plan’s financial statements. References made to FASB guidance throughout this document have been updated for the Codification.
 
In January 2010, the FASB issued authoritative guidance to require additional disclosures about the different classes of assets and liabilities measured at fair value, the valuation techniques and inputs used, the activity in Level 3 fair value measurements and the transfers between Levels 1, 2, and 3. The disclosure requirements are related to recurring and nonrecurring fair value measurements. The adoption of the new guidance did not have an impact on the Plan’s financial statements.
 
In February 2010, the Financial Accounting Standards Board (“FASB”) issued amended guidance to require an SEC filer to evaluate subsequent events through the date the financial statements are issued with the SEC. The amended guidance adds the definitions of an SEC filer and revised financial statements and no longer requires that an SEC filer disclose the date through which subsequent events have been reviewed. It also removes the definition of a public entity. The adoption of the new guidance did not have an impact on the Plan’s disclosures, and financial statements.
 


 
-6-
 
 

 

 
3.
INVESTMENTS
 
 
The Plan’s investment in Company common stock experienced net appreciation/(depreciation) in value as follows for the years ended June 30, 2010, 2009, and 2008:
 

   2010    2009    2008
 
£
  
£
  
£
The Procter & Gamble Company
          
  common stock:
          
    Net appreciation/(depreciation)
         9,577,951
  
          (347,715)
  
            (23,872)


4.
AMOUNTS DUE TO OTHERS
  
 
   
2010
  
2009
   
£
  
£
         
Amounts due to members
  
               76,525
  
               60,977
Amounts due to participating Procter & Gamble companies
               26,925
  
                 9,022
Amounts due to Capita IRG Trustees Limited
  
                 1,099
  
                 1,099
   
             104,549
  
               71,098

5.
TAX STATUS
 
HM Revenue & Customs (HMRC) has determined and informed the Company that it is an approved Employee Share Scheme under UK tax legislation.  Therefore, the Plan Administrator believes that the Plan was qualified and tax-exempt as of June 30, 2010 and no provision for income taxes has been reflected in the accompanying financial statements.
 
6.
RELATED PARTY TRANSACTIONS
 
At June 30, 2010 and 2009, 1,132,980 and 1,070,923 shares of Company common stock were held by the Plan, respectively. The cost of this stock at June 30, 2010 and 2009, was £35,460,484 and £33,195,410, respectively. During the years ended June 30, 2010, 2009 and 2008, the Plan recorded dividend income from Company common stock of £1,045,462, £849,992, and £522,807, respectively. Contributions from participating Procter & Gamble companies of £3,503,180,  £3,483,476, and £3,577,341 were recorded for the years ended June 30, 2010, 2009 and 2008, respectively. Also, the Plan received reimbursements for adminstrative expenses from the Company titled Income From The Procter & Gamble Company in the Statements of Changes in Net Assets Available For Plan Benefits for the years ended June 30, 2010, 2009 and 2008 of £35,297, £17,045, and £11,562, respectively.
 
7.
PLAN TERMINATION
 
 
Although it has not expressed any intent to do so, the Company has the right under the Plan to discontinue its contributions at any time and to terminate the Plan subject to the provisions set forth in the Plan agreement.
 

 



 
-7-
 
 

 

8.
PARTICIPATING PROCTER & GAMBLE COMPANIES
 
The participating Procter & Gamble companies are as follows:
 
Procter & Gamble Pharmaceuticals UK Limited (up to 30th October 2009)
Procter & Gamble Prestige Products Limited
Procter & Gamble Product Supply (UK) Limited
Procter & Gamble Technical Centres Limited
Procter & Gamble (L&CP) Limited
Procter & Gamble (Health & Beauty Care) Limited
Gillette UK Limited
Gillette Management LLC
Wella (UK) Limited
Wella (UK) Holdings Limited

 
-8-
 
 



THE PLAN.  Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Newcastle upon Tyne United Kingdom, on September 28, 2010.
 
PROCTER & GAMBLE 1-4-1 PLAN
 
By:       /s/ SUSAN E. CARVER 
Ms. Susan E. Carver
Trustee,
Procter & Gamble 1-4-1 Plan
 
 
 
EXHIBIT INDEX
 
Exhibit No.                                                                                                 Page No.
      23                                Consent of Deloitte LLP              10


 
-9-
 
 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
We consent to the incorporation by reference in the Registration Statement No. 333-100561 of The Procter & Gamble Company on Form S-8 of our report dated 28 September 2010, appearing in this Annual Report on Form 11-K of The Procter & Gamble 1-4-1 Plan for the year ended 30 June 2010.
 
/s/ DELOITTE LLP
 
Newcastle upon Tyne, United Kingdom
 
28 September 2010
 
 
 
 
 
 
-10-